The pandemic has also thrust life sciences onto the global center stage. Novel biotechnology has gone from an arcane topic to one that dominates news broadcasts and casual conversations. With a growth rate of 7 percent anticipated by 2028, the life science industry is expanding, on average, faster than any other.
With all workplaces rattled by labor shortages, and all eyes on drug development, the pandemic’s perfect storm is even tougher on life sciences. The key to weathering it is a combination of smart technology and streamlined processes. Let’s look at the problems you may face, now and in the future, and their solutions.